Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone - Concepedia

Concepedia

Publication | Open Access

Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone

DOI Full Paper Access

934

Citations

18

References

1994

Year

John J. Nolan, Bernhard Ludvik, P. Beerdsen, M. Joyce, Jerrold M. Olefsky

New England Journal of Medicine

Abstract

Troglitazone decreases insulin resistance and improves glucose tolerance in obese subjects with either impaired or normal glucose tolerance. The ability of troglitazone to reduce insulin resistance could be useful in preventing NIDDM:

References

	Year	Citations
Banting lecture 1988. Role of insulin resistance in human disease Gerald M. Reaven Diabetes Insulin ResistanceMetabolic SyndromeDiabetes ManagementLecture 1988Insulin Management	1988	3.8K
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT* Robert D. Steele Annals of the New York Academy of Sciences Metabolic SyndromeHepatologyLiver PhysiologyDiabetesPhysiology	1959	1.7K
Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima Indians Stephen Lillioja, David M. Mott, Maximilian Spraul, New England Journal of Medicine	1993	1.5K
Slow Glucose Removal Rate and Hyperinsulinemia Precede the Development of Type II Diabetes in the Offspring of Diabetic Parents James H. Warram Annals of Internal Medicine	1990	1.1K
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus Johan G. Eriksson, A. Franssila-Kallunki, Agneta Ekstrand, New England Journal of Medicine	1989	820
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. Richard N. Bergman, Rudolf Prager, Jerrold M. Olefsky Journal of Clinical Investigation Minimal Model ApproachEuglycemic Glucose ClampObesityMetabolic SyndromeInsulin Sensitivity Index	1987	777
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. Orville Kolterman, R S Gray, Justin W. Griffin, Journal of Clinical Investigation Noninsulin-dependent Diabetes MellitusType IiInsulin SignalingObesityMetabolic Syndrome	1981	635
Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects Stephan L. Suter, John J. Nolan, Penny Wallace, Diabetes Care	1992	424
Minimal Model Analysis of Intravenous Glucose Tolerance Test-Derived Insulin Sensitivity in Diabetic Subjects* Susan Welch, Suzanne S P Gebhart, Richard N. Bergman, The Journal of Clinical Endocrinology & Metabolism	1990	341
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance Takashi Kadowaki, Y. Miyake, Ryoko Hagura, Diabetologia ObesityMetabolic SyndromeDiabetes ManagementCardiovascular DiseaseGlobal Health	1984	319

Page 1